Compared to NF1 patients with intragenic mutations, patients with the 17q11.2 microdeletion typically have a higher number of cutaneous and subcutaneous neurofibromas (more than 1000) and earlier onset (prepubertal). The gene discussed is NF1; the disease is neurofibroma.